Tzipi Ozer-armon
Chief Executive Officer
Business Management
Lumenis
Israel
Biography
Ms. Tzipi Ozer-Armon, CEO of Lumenis, joined the company in May 2012. Before joining Lumenis, Ms. Ozer-Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), a business with a turnover of more than $800M. Prior to that, Ms. Ozer-Armon served as Senior Vice President of Sales and Marketing at SanDisk (Nasdaq:SNDK), having multi-billion dollars sales’ responsibility; she also served as VP & General Manager of MSystems (Nasdaq: FLSH), and as VP of Corporate Development at Comverse (Nasdaq: CMVT). Ms. Ozer-Armon’s impressive career also includes four years at ATKearney, a Global Management Consulting company based in London, UK. Ms. Ozer-Armon holds a BA magna cum laude in Economics from Tel Aviv University, an MBA majoring in Finance and Marketing, and she is an AMP graduate of the Harvard Business School. Ms. Tzipi Ozer-Armon, CEO of Lumenis, joined the company in May 2012. Before joining Lumenis, Ms. Ozer-Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), a business with a turnover of more than $800M. Prior to that, Ms. Ozer-Armon served as Senior Vice President of Sales and Marketing at SanDisk (Nasdaq:SNDK), having multi-billion dollars sales’ responsibility; she also served as VP & General Manager of MSystems (Nasdaq: FLSH), and as VP of Corporate Development at Comverse (Nasdaq: CMVT). Ms. Ozer-Armon’s impressive career also includes four years at ATKearney, a Global Management Consulting company based in London, UK. Ms. Ozer-Armon holds a BA magna cum laude in Economics from Tel Aviv University, an MBA majoring in Finance and Marketing, and she is an AMP graduate of the Harvard Business School.
Research Interest
Business Management
